BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32883509)

  • 1. Jaw osteonecrosis related to cabozantinib.
    Sánchez López JD; Rodríguez Ruiz JA; Miguel PPT
    Med Clin (Barc); 2021 Jun; 156(12):627-628. PubMed ID: 32883509
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaw in a patient receiving cabozantinib.
    Marino R; Orlandi F; Arecco F; Gandolfo S; Pentenero M
    Aust Dent J; 2015 Dec; 60(4):528-31. PubMed ID: 25474298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maxillar osteonecrosis related to denosumab. Evaluation of nine cases.
    Sánchez López JD; Cariati P; Pérez de Perceval Tara M
    Med Clin (Barc); 2020 Aug; 155(4):180-181. PubMed ID: 31427154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges.
    Schiodt M; Otto S; Fedele S; Bedogni A; Nicolatou-Galitis O; Guggenberger R; Herlofson BB; Ristow O; Kofod T
    Oral Dis; 2019 Oct; 25(7):1815-1821. PubMed ID: 31325201
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 8. Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Ferneini EM
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1801-1802. PubMed ID: 34334170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in the research of bisphosphonate-associated osteonecrosis of the jaws].
    Ruan M; Ji T; Zhang CP
    Shanghai Kou Qiang Yi Xue; 2006 Dec; 15(6):663-7. PubMed ID: 17533726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-Related Osteonecrosis of the Jaw.
    Chen YF; Chang HP
    N Engl J Med; 2023 May; 388(21):e69. PubMed ID: 37212416
    [No Abstract]   [Full Text] [Related]  

  • 11. Pembrolizumab related osteonecrosis of the jaw.
    Patel V; Carey B
    Br J Oral Maxillofac Surg; 2023 Dec; 61(10):704-706. PubMed ID: 37957097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab related osteonecrosis of the jaw: Unusual pattern with periosteal reaction.
    Tagliamento M; Boutros C; Viansone A; Brau JJ; Descols P
    Eur J Cancer; 2022 May; 166():33-37. PubMed ID: 35272085
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: AAOMS Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.
    Campisi G; Mauceri R; Bedogni A; Fusco V
    J Oral Maxillofac Surg; 2022 Nov; 80(11):1723-1724. PubMed ID: 36332990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bisphosphonate-related osteonecrosis of the jaw].
    Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
    Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
    Chang JI; Hazboun RC; Chang TI
    J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis.
    Gavrić M; Antić S; Jelovac DB; Zarev AI; Petrović MB; Golubović M; Antunović M
    Vojnosanit Pregl; 2014 Aug; 71(8):772-6. PubMed ID: 25181838
    [No Abstract]   [Full Text] [Related]  

  • 19. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX.
    Schwartz HC
    J Oral Maxillofac Surg; 2015 Mar; 73(3):377. PubMed ID: 25683041
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary--Is the bone turnover of the jawbone and its possible over suppression by bisphosphonates of etiological importance for the pathogenesis of the bisphosphonate-related osteonecrosis?
    Carlson ER; Gerard DA
    J Oral Maxillofac Surg; 2014 May; 72(5):911-3. PubMed ID: 24480759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.